bluuebunny/crossref_metadata_2025_split huggingface dataset:
Public policy and corporate environmental behaviour: a broader view
Authors: Sarkar Runa 
Published: November 2007

AbstractCorporate strategies to manage the business–ecological environment interface have evolved against the backdrop of regulatory pressures and stakeholder activism. Despite its relevance with respect to sustainable development, a well developed theory encompassing all aspects of corporate environmental behaviour, especially incorporating incentive compatible public policy measures, is yet to be developed. This paper is a step in this direction, aiming to assimilate contributions related to different aspects of corporate environmental behaviour, capturing the transition from environmental management to environmental strategy. In the process we identify areas where there is a need for further research. We find that there is plenty of scope in developing more complex models to explain a manager's rationale for adopting sustainable strategies in the backdrop of the policy regime, and in conducting more empirical (both descriptive and quantitative) work to obtain clearer insights into managerial decisions. Copyright © 2007 John Wiley & Sons, Ltd and ERP Environment.
UEEDA: Uniform and energy‐efficient deployment algorithm for wireless sensor networks
Authors: Weng Chien‐Erh , Lain Jenn‐Kaie , Zhang Jia‐Ming , Wen Jyh‐Horng 
Published: November 2007

AbstractEfficient and accurate sensor deployment is a critical requirement for the development of wireless sensor networks. Recently, distributed energy‐efficient self‐deployment algorithms, such as the intelligent deployment and clustering algorithm (IDCA) and the distributed self‐spreading algorithm (DSSA), have been proposed to offer almost uniform distribution for sensor deployment by employing a synergistic combination of cluster structuring and a peer‐to‐peer deployment scheme. However, both DSSA and IDCA suffer from unnecessary movements that have arisen from an inappropriate design in partial force. To improve the performance of self‐deployment algorithms, a uniform and energy‐efficient deployment algorithm (UEEDA) is proposed in this paper. Simulation results demonstrate that the proposed UEEDA outperforms both DSSA and IDCA in terms of uniformity and algorithm convergence speed. Copyright © 2007 John Wiley & Sons, Ltd.
Validity of rapid cycling as a modifier for bipolar disorder in DSM‐IV
Authors: Bauer Mark S. , Brow Peter C. Why 
Published: November 2007

AbstractData are reviewed regarding the validity of rapid cycling as a modifier for Bipolar Disorder, as defined by the Dunner‐Fieve criterion of at least four affective episodes in 12 months. This formulation is evaluated in light of the criteria for validity suggested by Robins and Guze and by Kendell. While available data support recognition of rapid cycling as a modifier, a number of issues remain. These include particularly the optimal cut‐off for rapid cycling in terms of number of episodes per year, and whether brief but severe episodes should be counted towards that criterion. Several options for operational zed criteria sets are discussed. Depression 1:11–19 (1993). Published 1993 by Wiley‐Liss, Inc.
An investigation of ophthalmic function in winter seasonal affective disorder
Authors: Oren Dan A. , Moul Douglas E. , Schwartz Paul J. , Alexander Joseph R. , Yatnada Emily M. , Rosenthal Norman E. 
Published: November 2007

AbstractTo evaluate the possibility that abnormalities in visual functioning may be of importance in winter seasonal affective disorder (SAD), we compared various ophthalmological function tests by drawing subsets of a group of 61 patients and 61 normal controls. We measured dark adaptation with a Goldmann‐Weekers dark adept meter in winter and summer. In winter we also measured intraocular pressure with an applanation tonometer while ‘off’ and “on” light therapy, pupillary size by measuring pupillaryphotos, color vision with a Nagelanomaloscope and the Farnsworth‐Munsell 100 Hue test, and determined b‐wave components of pattern electroretinograms and P100 components of pattern visual evoked potentials. We found no significant differences between patients and controls. These observations have direct implications upon different theories linking SAD to abnormal ophthalmic junction. This body of work provides little evidence to link SAD to an intrinsic ophthalmic defect in the electrophysiological and neurological pathways studied. Depression 1:29–37 (1993). Published 1993 by Wiley‐Liss, inc.
Reduction of cerebellar volume in major depression: A controlled MRI study
Authors: Escalona P. Rodrigo , Early Bridget , McDonald William M. , Doraiswamy P. Murali , Shah Sunjay A. , Husain Mustafa M. , Boyko Orest B. , Figiel Gary S. , Ellinwood Everett H. , Nemeroff Charles B. , Krishnan K. Ranga R. 
Published: November 2007

AbstractA systematic sampling stereological method of serially acquired axial intermediate T2‐weighted Spin echo magnetic resonance imaging (MRI) of the brain was used to measure cerebellar volume in 30 patients who fulfilled DSM III criteria for major depression and compared with 35 normal controls. The mean cerebellar volume of depressed patients was significantly smaller than the controls. This preliminary study adds new evidence for the possible participation of the cerebellum in the pathophysiology of major depression and warrants further investigation in this area. Depression 1:156–158 (1993). © 1993 Wiley‐Liss, Inc.
Magnetic‐resonance morphometry: Image‐analysis methodology development for affective disorder
Authors: Krishnan K. Ranga R. , Boyko Orest B. , McDonald William M. , Charles H. Cecil , Macfall James R. , Tupler Larry A. , Upchurch Lucy W. 
Published: November 2007

AbstractIn this article we review some important methodological issues for measurement of brain structures and lesions visualized on magnetic resonance (MR) imaging. Such issues include the method of sectioning, number of slices, shape of the structure, orientation of the slices, and fuzziness of the edges. Sources of error specific to morphometry obtained from MR scans are also considered, including issues of partial volume, contrast and itensity changes, and magnetic‐field inhomogeneties. Each of these factors is important and should be borne in mind while undertaking MR studies for morphometry. In addition, a key element contributing to variability in the assessment of structures is the anatomical definition of specific brain regions. We briefly summarize the anatomical definitions that are useful in assessing many relevant brain areas and for evaluating signal hyperintensities that are frequently found in elderly patients with affective disorder. The reliability of assessment using these methods is noted. Studies of neuroanatomical changes associated with affective disorder will benefit from further improvement in the reliability and accuracy of MR morphometric methods. Depression 1:159–171 (1993). © 1993 Wiley‐Liss, Inc.In this article we have reviewed some of the important methodological issues for measurement of brain structures and lesions visualized on MR. These issues should be borne in mind while undertaking MR studies for morphometry. In addition, a key element contributing to variability in the assessment of structures is the anatomical definition of specific brain regions. We have briefly summarized the anatomical definitions we have found useful in assessing many relevant brain areas and for evaluating signal hyperintensities that are frequently seen in elderly patients with affective disorder. The reliability of assessment using these methods is noted. In addition to these factors, image‐acquisition methods can also affect measurement. However, these factors have not been well studied and are not addressed in this article. We have also not compared different image‐analysis systems. This is an extremely important undertaking that has yet to be conducted. Future studies of neuroanatomical changes in affective disorder will benefit from further improvement in reliability and accuracy of MR morphometric methods. Deparession 1:159–171 (1993). © 1993 Wiley‐Liss, Inc.
Depression in the course of treatment of generalized anxiety disorder with lorazepam, ipsapirone, and placebo: Results from a multicenter trial
Authors: Sramek John J. , Cutler Neal R. , Costa Jerome F. , Hesselink Jan M. Keppel , Seifert Randall D. , Graham Evelyn 
Published: November 2007

AbstractThe present report addresses the occurrence of depression during a multicenter, double‐blind, randomized, placebo‐controlled trial investigating the comparative anxiolytic efficacy of ipsapirone and lorazepam versus placebo in generalized anxiety disorder (GAD). Patients who entered the study scored ≥18 on the HAM‐A, scored ≥ 8 on the Covi anxiety scale, and scored ⩽ 7 on the Raskin depression scale. Patients were randomized to lorazepam (2–6 mg/day), ipsapirone (10–30 mg), or placebotid for 4 weeks acute treatment. Efficacy of ipsapirone versus lorazepam and placebo in GAD was assessed with weekly HAM‐A and CGI ratings. Worsening or emergence of depression was assessed with HAM‐D ratings performed at baseline and weeks 2 and 4. Adverse events were assessed weekly. Ninety‐six males and 161 females (age range 18–78 years) were valid for efficacy after a 4‐week acute treatment period. HAM‐A and CGI scores were significantly reduced with lorazepam and ipsapirone compared with placebo. HAM‐D scores were also reduced significantly from baseline in the lorazepam, ipsapirone, and placebo groups; HAM‐D core items significantly decreased in the ipsapirone but not in the lorazepam and placebo groups. Individual incidents of depression showed significantly (p < 0.05) higher frequency in the lorazepam group (10/104; 9.6%) compared with ipsapirone (2/106; 1.9%), but only a trend (p < 0.10) compared with placebo (4/105; 3.8%). There was an increased severity of the depressive incidents in the lorazepam group compared with the other two treatment groups. This report confirms an earlier study reporting that depression is a potential side effect of lorazepam treatment in GAD patients. Depression 1:172–176 (1993). © 1993 Wiley‐Liss, Inc.
Antidepressants and HIV infection: Effect of lithium chloride and desipramine on HIV replication
Authors: Evans Dwight L. , Smith Marilyn S. , Golden Robert N. 
Published: November 2007

AbstractThere is increasing evidence that depression occurs in a significant number of individuals with HIV infection. Consequently, antidepressant medication treatment is often prescribed in an attempt to alleviate depressive symptoms and improve the quality of life. However, psychopharmacologic agents have direct effects on the immune system. Therefore we studied the effects of lithium chloride and the tricyclic antidepressant, desipramine, on HIV replication in T lymphocytes in culture. The effect of lithium on reverse transcriptase activity was also studied in vitro. Neither lithium nor desipramine had an effect on HW replication, and lithium had no effect on virus‐associated reverse transcriptase activity. Although these results suggest that lithium and desipramine can be used without adverse effects on HIV replication for the treatment of depression in HIV‐infected individuals, in vivo effects can not be ruled out by these in vitro findings. Depression 1:205‐209 (1993). © 1993 Wiley‐Liss, Inc.
Plasma homovanillic acid in psychotic depression
Authors: Devanand D. P. , Gotto Jennifer G. , Cooper Thomas B. , Fitzsimons Linda , Sackeim Harold A. 
Published: November 2007

AbstractElevated levels of plasma homovanillic acid (HVA) are associated with increased psychopathology after neuroleptic withdrawal in schizophrenia, and may be predictive of treatment response in psychotic patients. There are limited extant data on plasma HVA in psychotic and non‐psychotic major depression. In 53 medication‐free inpatients with endogenous depression, single determinations of AM plasma HVA did not differ between psychotic (n = 20) and non‐psychotic (n = 33) patients. Plasma HVA showed no associations with age, gender, or indices of disease severity. Consistent with prior reports, a course of ECT treatment did not significantly change plasma HVA levels in this depressed sample, and there were no effects of ECT modality or clinical response on plasma HVA levels.These results, though limited by the absence of serial sampling, suggest that plasma HVA abnormalities may not characterize psychotic depression, unlike the findings in schizophrenia. The existence of multiple subtypes of dopamine receptors, and the possibility of different abnormalities in the mesolimbic and prefrontal dopaminergic pathways in schizophrenia, complicates the interpretation of peripheral dopaminergic markers. The significance of peripheral markers such as plasma HVA remains uncertain, though at this stage the clinical correlates in schizophrenia are better established than those in psychotic depression. Further work is necessary to clarify the utility of peripheral markers of the dopamine system in psychotic disorders. Depression 1:309–314 (1993). © 1993 Wiley‐Liss, Inc.
Prefrontal cortex dysfunction in clinical depression
Authors: George Mark S. , Ketter Terence A. , Post Robert M. 
Published: November 2007

AbstractThe role of specific brain regions in the pathophysiology of clinical depression is poorly understood. However, one brain area, the prefrontal cortex, is emerging as likely being directly involved in clinical depression. The authors review accepted clinical diagnostic criteria for depression and show how these relate to the behavioral changes seen after prefrontal cortex damage in man and other animals. Information from structural (MRI, CT) and functional imaging (SPECT, PET) is then examined for direct evidence of prefrontal cortex abnormalities in clinically depressed subjects. Functional imaging studies, with few exceptions, demonstrate prefrontal lobe hypometabolism in primary and secondary depression, with severity of depression often correlating with the degree of frontal inactivity. These studies imply that dysfunction of the prefrontal cortex, particularly with respect to its role in modulating limbic activity, could conceivably produce many of the symptoms seen in clinical depression. Viewing clinical depression as a disease involving dysfunction of the prefrontal cortex and connected brain regions may prove helpful in both the clinical management of depression and in clarifying future avenues for research. Depression 2:59–72 (1994). © 1994 Wiley‐Liss, Inc.
Buspirone treatment of sexual dysfunction associated with selective serotonin re‐uptake inhibitors
Authors: Norden Michael J. 
Published: November 2007

AbstractA retrospective study was done of sixteen patients treated with adjunctive buspirone in the context of sexual dysfunction associated with the use of selective serotonin re‐uptake inhibitors (SSRls). Sexual functioning was rated as much or very much improved in 11 patients (69%). Treatment was generally very well tolerated. However, several patients who had become less irritable after treatment with an SSRI, reported increased irritability. The results suggest adjunctive buspirone may be useful in the management of sexual dysfunction associated with SSRIs; possible mechanisms of action are discussed. Depression 2:109–112 (1994). © 1994 Wiley‐Liss, Inc.
Tricyclics and newer antidepressant medications: Treatment options for treatment‐resistant depressions
Authors: Thase Michael E. , Rush A. John , Kasper Siegfried , Nemeroff Charles B. 
Published: November 2007

AbstractOnly about 60–70% of those depressed patients who can tolerate an antidepressant medication, and only about 50–60% of those who begin a medication will respond to the first trial. Furthermore, 5–10% will remain depressed despite multiple medication trials. When the disorder is poorly responsive, it is variously described as a resistant, refractory, or intractable depression. This review summarizes the available literature on treatment‐resistant depression (TRD) to provide recommendations for the most rational alternative strategies. Depression 2:152–168 (1994/1995). © 1995 Wiley‐Liss, Inc.
Psychosocial interventions in bipolar disorder
Authors: Zaretsky Ari E. , Segal Zindel V. 
Published: November 2007

AbstractMood‐stabilizing pharmacotherapy has become the mainstay of treatment for bipolar disorder (BD). Despite the increasingly biological conceptualization of illness, psychosocial interventions may also have a role to play in the treatment of manic‐depressive illness. This article aims to provide a comprehensive and critical review of the literature on the use of psychosocial interventions for BD. The general therapeutic processes underlying the effectiveness of these different psychologically based interventions will also be discussed. All papers listed in Medline and Psychological Abstracts published since 1970 on the use of psychosocial interventions for BD were examined and reviewed with regards to efficacy. The evidence suggests that psychosocial interventions combined with mood‐stabilizing medication are associated with superior clinical outcome compared to treatment with mood‐stabilizing medication alone. Seven unique therapeutic mechanisms may underlie the effectiveness of these various psycho‐social interventions, including: closer monitoring of affective symptomatology, earlier environmental modification, enhanced compliance with medication, enhanced social support, improved familial adjustment, regulation of daily routines, and enhancement of coping strategies. Psychosocial interventions have a beneficial effect on clinical outcome in BD. More rigorous controlled research is needed to replicate these initial outcome studies. What also remains to be clarified is whether psychologically based interventions possess unique therapeutic potency independent of their effects on medication compliance. Depression 2:119‐188 (1994/1995). © 1995 Wiley‐Liss, Inc.
Longitudinal study of social support and social conflict as predictors of depression and dysphoria among HIV‐positive and HTV‐negative gay men
Authors: Leserman Jane , Disantostefano Rachael , Perkins Diana O. , Murphy Carol , Golden Robert N. , Evans Dwight L. 
Published: November 2007

AbstractAlthough there is an abundance of literature linking social support and mental health, less attention has been paid to the psychological effects of social conflict. In a sample of HIV‐positive and HIV‐negative gay men, the present study focuses on: (1) how support satisfaction and frequency of social conflict correlate with measures of depression and other aspects of mental health at study entry, and (2) whether changes in social support or social conflict are related to changes in psychological status over a 1‐year period. The sample was composed of 108 asymptomatic HIV‐positive and 73 HIV‐negative gay men. One‐year follow‐up data were available on 84 HIV‐positive and 63 HIV‐negative men. We found that: (1) psychological disturbance was related to frequent social conflict, and to a lesser extent, dissatisfaction with social support; and (2) increased psychological disturbance over 1‐year was correlated with increased social conflict, and to a lesser extent, decreased support satisfaction. The pattern of relationships over time between changes in social interaction and changes in psychological health was slightly different far the serostatus groups. Social conflict and support satisfaction may have relevance far the psychological health of gay men. Depression 2:189—199 (1994/1995). © 1995 Wiley‐Liss, Inc.
“Double bipolar disorder”: A separate entity?
Authors: Young L. Trevor , Cooke Robert G. , Robb Janine C. , Joffe Russell T. 
Published: November 2007

AbstractThe comorbidity of bipolar disorder with cyclothymiacs was examined. Eased on the SADS‐L, patients with co morbid cyclothymiacs experience more anxiety symptoms, more severe depressions, and greater impairment in functioning and well being, this latter finding confirmed by the Medical Outcomes Survey (MOS) subscale scores. Treatment outcome did not differ between the groups, which possibly related to limitations in the experimental design. Depression 2:223–225 (1994/1995). © 1995 Wiky‐Liss, Inc.
Lithium‐thyroid interactive hypothesis of neuropsychological deficits: A review and proposal
Authors: Prohaska Mark L. , Stern Robert A. , Steketee Mareah C. , Prange Arthur J. 
Published: November 2007

AbstractAlthough lithium carbonate is a mainstay in the treatment of mood disorders, especially bipolar illness, its use is attended by a high incidence of side effects. Physical side effects are usually addressed effectively by the psychiatrist, but neuropsychological side effects often go untreated and thus may contribute to a high rate of drug non‐compliance. Evidence from a variety of sources indicates that the major neuropsychological effect of lithium is a generalized psychomo‐tor slowing that manifests itself in subjective complaints of impaired thinking ability, a sense of lethargy, and memory dysfunction. The objective techniques of neuropsychological testing have begun to dissect the discrete aspects of cognition and memory that may be impaired by lithium. Although the neuropsychological deficits of hypothyroidism have not yet been subjected to detailed study, the deficits caused by lithium appear to be consistent with those encountered in patients with hypothyroidism, whether overt or subclinical. Relevant to this comparison is the fact that lithium is a potent antithyroid drug. For these reasons, it is justified to state as a hypothesis that at least some of the neuropsychological deficits caused by lithium are attributable to their antithyroid effects. This hypothesis provides directions for future research in this area and has potentially important implications for treating the neuropsychological side effects of lithium. Depression 2:241–251 (1994/1995). © 1995 Wiley‐Liss, Inc.
Pregnant or depressed? The effect of overlap between symptoms of depression and somatic complaints of pregnancy on rates of major depression in the second trimester
Authors: Klein Marjorie H. , Essex Marilyn J. 
Published: November 2007

AbstractThis study investigated the relationship between symptoms of major depression that were attributed either to stress or to pregnancy among women in the second trimester and considered the effect of symptom overlap on diagnostic outcome. A sample of 570 obstetrical clinic patients were given the depression section of the Diagnostic Interview Schedule, with questions added about pregnancy as a cause of somatic symptoms. In this sample, some of the common symptoms of depression such as increased appetite and fatigue were attributed more frequently to pregnancy than to stress. When pregnancy‐related symptoms were included in the scoring for DSM‐III‐R major depression, the rate for the current pregnancy rose from 1.2 to 2.8 percent and the rate for lifetime major depression rose from 5.6 to 10.9%. Comparisons on measures of family history, self‐report depression, and personality between subjects with “pure” depression and those with “mixed” symptom pictures suggest that the latter may he a spectrum group. In the discussion we speculate that the overlap between symptoms of depression and complaints associated with pregnancy may bias estimates of depression in studies of women of childbearing age. Depression 2:308–314 (1994/1995). © 1995 Wiley‐Liss, Inc.